Hogan Lovells Events | 17 October 2024 | 12:00 p.m. - 1:30 p.m. (EST)

The Supreme Court’s Loper Bright and Corner Post decisions—what now for pharma?

In two decisions issued at the end of the 2023 Supreme Court term, the Court overruled the 40-year-old Chevron doctrine, which required courts to defer to agencies’ reasonable interpretations of ambiguous or silent statutes (Loper Bright); and extended the window to challenge certain agency actions in certain circumstances (Corner Post).

In this program, we’ll discuss what is and isn’t a Loper Bright issue; how industry can and should play offense and defense following the Court’s decisions; and some areas that may—and may not—be ripe for reconsideration following Loper Bright and Corner Post.